Literature DB >> 7509133

Incidence of CD4+ IL-2R alpha+ and CD4+ CD45RA+ T-cells in progressive multiple sclerosis and the influence of short-term (3 months) FK 506 therapy.

A W Thomson1, J Woo, B Lemster, W Irish, L L Huang, P B Carroll, H R Rilo, K Abu-Elmagd, B Eidelman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 7509133     DOI： 10.1111/j.1749-6632.1993.tb17157.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN： 0077-8923            Impact factor:   5.691


× No keyword cloud information.
  2 in total

1.  Influence of FK 506 (tacrolimus) on circulating CD4+ T cells expressing CD25 and CD45RA antigens in 19 patients with chronic progressive multiple sclerosis participating in an open label drug safety trial.

Authors:  B Lemster; L L Huang; W Irish; J Woo; P B Carroll; K Abu-Elmagd; H R Rilo; N Johnson; R Russell-Hall; J J Fung
Journal:  Autoimmunity       Date:  1994       Impact factor: 2.815

2.  Pseudolycorine chloride ameliorates Th17 cell-mediated central nervous system autoimmunity by restraining myeloid-derived suppressor cell expansion.

Authors:  Gan Zhang; Xinying Zhu; Fan Yang; Juan Li; Xiao Leng; Chunfen Mo; Limei Li; Yantang Wang
Journal:  Pharm Biol       Date:  2022-12       Impact factor: 3.889
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.